The Stockholm Convention Secretariat meeting page indicates that POPRC-22 is scheduled in Rome, Italy (21–25 September 2026) and will consider a revised draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans (mixed PBDD/PCDD/Fs). The page also notes POPRC-21 deferred its decision and invited additional Annex E information. For compliance monitoring, this is a process signal that these substances remain under active evaluation and could lead to future listing recommendations to the COP.
The Stockholm Convention Secretariat published the official schedule and key agenda focus for the 22nd meeting of the Persistent Organic Pollutants Review Committee (POPRC-22), to be held 21–25 September 2026 in Rome, Italy (FAO HQ). The posted overview highlights that POPRC will consider the revised draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans, including requests for additional Annex E information. This is relevant to regulatory horizon-scanning because POPRC outcomes can advance candidate chemicals through the Article 8 process toward possible future listing decisions by the COP.
The Stockholm Convention published the meeting overview page for the twenty-second meeting of the Persistent Organic Pollutants Review Committee (POPRC.22), scheduled for 21–25 September 2026 in Rome. While not a binding legal amendment, publication of the official meeting page signals active review activity (including consideration of revised draft risk profiles) that can lead to future POP listing recommendations. Compliance teams may use this to anticipate upcoming scientific/regulatory evaluations and potential future controls.
The Stockholm Convention Secretariat opened an invitation for Parties/observers to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. This is a POPs Convention process step that may affect continuation, modification, or expiration of the exemption and therefore future availability of this exemption pathway for regulated entities and supply chains.
The Stockholm Convention Secretariat published an invitation for Parties and stakeholders to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. This consultation may inform whether the exemption is continued, modified, or allowed to expire, which is relevant for pharmaceutical supply chains relying on this specific exemption pathway.
The Stockholm Convention Secretariat issued a communication inviting Parties and observers to submit comments on a draft report reviewing the specific exemption covering the use of perfluorooctyl iodide (PFOI) for the production of perfluorooctyl bromide (PFOB) for the purpose of producing pharmaceutical products. The communication sets a comment deadline of 22 May 2026. Compliance teams supporting pharmaceutical supply chains and Parties relying on this exemption should monitor the review outcome, as it may lead to changes to the scope, conditions, or continuation/expiry of the exemption under the Convention’s register of specific exemptions.
The Stockholm Convention Secretariat posted an invitation for Parties and stakeholders to submit comments on a draft report reviewing the specific exemption for use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for the purpose of producing pharmaceutical products. Compliance teams in affected supply chains (fluorochemicals and pharma intermediates) should review the draft review report and submit technical/economic information within the stated comment window, as outcomes can inform whether the exemption is continued, modified, or allowed to expire in future COP decisions.
The Stockholm Convention Secretariat issued an invitation to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for the production of pharmaceutical products. The communications listing specifies a comment deadline of 22 May 2026. Compliance teams should monitor this exemption review because the outcome can change the continued availability/conditions of the exemption and may trigger updates to national implementation measures for affected pharmaceutical supply chains.
The Stockholm Convention Secretariat issued a communication inviting Parties and observers to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. The communication sets a comment submission deadline of 22 May 2026. This matters for compliance because outcomes of exemption reviews can change conditions, scope, or continuation/expiry of permitted uses for Annex-listed POPs and may require companies supporting registered uses to adjust sourcing, product formulations, or documentation supporting continued lawful use in Parties relying on the exemption.
Defra launched an 8-week public consultation on proposed amendments to Great Britain’s POPs regime (GB-assimilated Regulation (EU) 2019/1021). The consultation seeks views on potential changes to Annex I restrictions to align with Stockholm Convention-related updates (including adding newly listed POPs/controls), which would affect compliance for manufacturers, importers, and waste handlers dealing with POPs-containing substances and articles.
Defra opened a public consultation on proposed legislative amendments to the GB-assimilated POPs Regulation (Regulation (EU) 2019/1021 as it applies in Great Britain). The proposal would add medium-chain chlorinated paraffins (MCCPs), long-chain perfluorocarboxylic acids (LC‑PFCAs; their salts and related compounds) and chlorpyrifos to Annex I (prohibitions on manufacture, use and placing on the market), alongside other substances. The consultation also seeks input on topics such as unintentional trace contaminant (UTC) limits and exemptions approach, which may affect compliance planning and product composition/supply-chain controls for GB market access.
New Zealand EPA opened a public consultation on proposed domestic implementation of the Stockholm Convention COP-12 (May 2025) listings of chlorpyrifos, medium-chain chlorinated paraffins (MCCPs), and long-chain perfluorocarboxylic acids (LC‑PFCAs; their salts and related compounds). The proposal involves amending Schedule 2A of the HSNO Act (and related schedules/references) to establish prohibitions/restrictions and align New Zealand controls with the Convention’s entry-into-force timeline referenced in EPA materials. Compliance teams should track the final national instruments, including any specific exemptions and import/export control interfaces referenced by EPA.
The Stockholm Convention Secretariat meeting page confirms the 22nd meeting of the Persistent Organic Pollutants Review Committee (POPRC-22) will be held 21–25 September 2026 in Rome (FAO HQ) and highlights that POPRC-22 will consider a revised draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans (mixed PBDD/PCDD/Fs). For compliance teams, this is a key procedural milestone in the Stockholm listing pipeline, indicating potential movement toward future global listing recommendations and eventual COP decisions for these substance groups.
The European Commission’s ‘International agreements (Chemicals)’ page states that at the 2025 Basel/Rotterdam/Stockholm COPs, Parties added three hazardous chemicals to the Stockholm Convention (chlorpyrifos; medium-chain chlorinated paraffins (MCCPs); and long-chain perfluorocarboxylic acids (LC‑PFCAs), their salts and related compounds). For compliance teams, this signals that these chemicals are now listed POPs under the Stockholm Convention, which typically drives Parties’ national implementation measures (production/use prohibitions or restrictions, trade controls, and waste management obligations) and may cascade into regional implementing legislation (e.g., EU POPs Regulation updates).
The European Commission’s ‘International agreements (Chemicals)’ page states that the Commission decided to close its proposal to nominate the siloxanes D4 (octamethylcyclotetrasiloxane), D5 (decamethylcyclopentasiloxane) and D6 (dodecamethylcyclohexasiloxane) under the Stockholm Convention. For compliance teams, this indicates the EU is no longer pursuing these substances for Stockholm Convention listing via its nomination route (at least as reflected in this update), which may affect expectations and internal regulatory watchlists for future global POP listing actions on these siloxanes.
The Stockholm Convention Secretariat invited comments on the (revised) draft risk profile evaluated within the POPs Review Committee (POPRC) process for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans (PBCDD/Fs and PBCDFs), excluding PCDD/Fs. Draft risk profile consultation is a key step toward potential future POPRC recommendations to list substances under the Convention (Annex A/B/C), which can subsequently drive global restrictions and downstream national/regional implementation.
The Stockholm Convention Compliance Committee initiated its 2026–2027 information-collection exercise by issuing questionnaires for Parties and supporting entities. The questionnaires are intended to collect updated information on implementation/compliance to support the Committee’s work programme and recommendations for consideration at a future COP (noted in the research as COP-13). Compliance teams supporting national authorities should ensure questionnaire completion and submission by the stated deadline, and coordinate internal data collection on measures taken to implement Stockholm Convention obligations.
The Stockholm Convention Secretariat posted an invitation to submit comments on a revised draft risk profile concerning polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans, and requested information pursuant to POPRC decision POPRC-21/6. This is part of the POPs Review Committee (POPRC) evaluation pathway that can lead to future recommendations to list substances under the Convention. Compliance teams should track this consultation as it signals potential future listing activity affecting brominated/chlorinated dioxin/furan-related materials and emissions management.
The Stockholm Convention Clearing-House Mechanism (CHM) meeting page indicates POPRC-22 will be held 21–25 September 2026 in Rome, Italy. The agenda includes consideration of a revised draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans, following a prior deferral and requests for additional Annex E information on linkages between long-range environmental transport and adverse human health effects. For compliance teams, this is an official process milestone that can signal future scope clarifications and potential future listing actions, informing substance monitoring and stakeholder engagement planning (e.g., preparing technical data submissions if relevant).
The Stockholm Convention CHM COP Decisions page is identified in the research as the official landing page to retrieve COP-12 outputs, including the report and the decisions adopted at the twelfth meeting (advance versions). For compliance teams, this page is an authoritative entry point for tracking adopted COP decisions that may include new listings, exemptions, technical guidance mandates, or compliance mechanisms requiring future implementation by Parties.